All News
Filter News
Found 12,123 articles
-
Amylin Pharmaceuticals, Inc., Eli Lilly and Company Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission; Review May Extend into 2009
12/8/2008
-
Eli Lilly and Company And Bristol-Myers Squibb Company Release: ERBITUX(R) Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. FDA
12/8/2008
-
Genomic Health, Inc. Announces Appointment of Ginger Graham to Board of Directors
12/8/2008
-
BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
12/3/2008
-
Eli Lilly and Company (JOBS) Pulls FDA Application for Cymbalta for Pain
12/1/2008
-
TorreyPines Therapeutics, Inc. Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly and Company (JOBS) for NGX426 and Tezampanel
11/25/2008
-
Eli Lilly and Company Completes Acquisition of ImClone Systems Incorporated
11/24/2008
-
Hutchison China MediTech (Chi-Med), Eli Lilly and Company (JOBS) Expand Drug Deal
11/21/2008
-
Eli Lilly and Company Buys Majority of ImClone Systems Incorporated in Tender Offer
11/21/2008
-
Life Science Weekly inSite (Nov. 14- Nov. 20)
11/21/2008
-
NitroMed, Inc. and Archemix Corporation Announce Merger Agreement
11/19/2008
-
Eli Lilly and Company Sues IMPAX Laboratories, Inc.
11/19/2008
-
Savient Pharmaceuticals, Inc.'s Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
11/19/2008
-
Mylan Inc. Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
11/18/2008
-
ImClone Systems Incorporated Announces Clearance of Tender Offer by German Federal Cartel Office
11/18/2008
-
Eli Lilly and Company Selects ICON-PLC to Manage its Clinical Data Management Business Outside the US
11/18/2008
-
Eli Lilly and Company (JOBS) Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics Corporation; Lilly Takes $150 Million Equity Stake in United Therapeutics
11/17/2008
-
Sirius Genomics Announces New Appointments to Board of Directors
11/14/2008
-
Ambrx, Inc. Release: Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
11/13/2008
-
Eli Lilly and Company Contributes $11.1 Million to United Way Annual Campaign Lilly's Gift Makes Up Nearly 23% of Fund Raising Goal for Central Indiana
11/13/2008